BioNanoTech, A Leader in Protein/Antibody Purification & Biological Testing Technology. Rapid Drug R&D and Production for the World.
At BioNanoTech, we are on a mission to save lives. We have solved the single most significant hurdle for biologic drug discovery. Our revolutionary size-invariant, ultra-high purity, and high yield protein and antibody purification technology platform unlocks the $265B market. Our platform creates new pathways for drug and vaccine discovery, production, and biological testing at a fraction of the previous lifetime costs. Our technology empowers the pharmaceutical and scientific community to expand their current production and revisit previous low-yield lines at the production scale, exposing new opportunities and turning waste into revenue so that no cure is left behind.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 23, 2017 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |